Bronchial biopsies cells count in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006
Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008
Bronchial biopsies composition in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007
Airway inflammatory cell compounds in smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 798s Year: 2006
Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Asthma control is worse in asthmatic smokers compared to non-smokers with similar lung function Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Characterization of lymphocyte subsets in the lungs of smokers and patients with COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005
Budesonide/formoterol significantly improves lung function and reduces exacerbations in both smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
Restoring corticosteroid sensitivity in COPD and smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008
Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005
The cellular composition and macrophage phenotypes in induced sputum in smokers and ex-smokers with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Bronchial airway expression of mucin-related, ENaC and chloride channel genes in COPD and non-COPD smokers compared to former and never smokers Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020